We mainly delivered a tailored therapy for a reduced LVEF or hypertension (ACE inhibitors) and symptom relief (like β-blockers for palpitations, or ACE inhibitors/diuretics for dyspnea). The gene discussed is ACE; the disease is Hypertension.